Literature DB >> 11593326

Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing.

F Nollet1, J Billiet, D Selleslag, A Criel.   

Abstract

To evaluate the origin of cells after allogeneic haematopoietic stem cell transplantation we optimised and evaluated two commercially available systems (AmpFlSTR Profiler Plus and GenePrint Powerplex-16) which are based on multiplex fluorescent short tandem repeat (STR) analysis. A standard procedure for interpretation of electropherographs was found essential to obtain reproducible results. On the basis of the relative length of donor and recipient alleles, TYPE-I (no shared alleles are used to calculate chimerism), TYPE-II (one shared and one unshared allele is used to calculate chimerism) or TYPE-III (not informative) allelic distribution types were distinguished. Also, stutter peaks were recognised as an important criterion to exclude a marker for analysis. Intralaboratory and multicentre evaluation of the AmpFlSTR Profiler Plus system showed that mixed blood samples could be determined with an absolute deviation of less than 2%. A sensitivity threshold was set at 5% for TYPE-I and 10% for TYPE-II markers since relative imprecision increases at low chimerism values. No significant difference of calculated chimerism values was observed between STR markers shared between both systems. By monitoring 26 allogeneic peripheral blood stem cell transplants, the applicability of the proposed method was demonstrated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593326     DOI: 10.1038/sj.bmt.1703162

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  29 in total

1.  Chimerism in DNA of buccal swabs from recipients after allogeneic hematopoietic stem cell transplantations: implications for forensic DNA testing.

Authors:  Burkhard Berger; Roswitha Parson; Johannes Clausen; Cordula Berger; David Nachbaur; Walther Parson
Journal:  Int J Legal Med       Date:  2012-03-09       Impact factor: 2.686

Review 2.  Hematologic aspects of myeloablative therapy and bone marrow transplantation.

Authors:  Roger S Riley; Michael Idowu; Alden Chesney; Shawn Zhao; John McCarty; Lawrence S Lamb; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  Systematic analysis of interference due to stutter in estimating chimerism following hematopoietic cell transplantation.

Authors:  Bharat Thyagarajan; Shawn Young; Stacy Floodman; Randolph Peterson; Xinjing Wang
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

4.  Long-term survival of donor bone marrow multipotent mesenchymal stromal cells implanted into the periosteum of patients with allogeneic graft failure.

Authors:  L A Kuzmina; N A Petinati; N V Sats; N J Drize; N V Risinskaya; A B Sudarikov; V A Vasilieva; M Y Drokov; E D Michalzova; E N Parovichnikova; V G Savchenko
Journal:  Int J Hematol       Date:  2016-05-12       Impact factor: 2.490

5.  Comparison of reduced conditionings combining fludarabine with melphalan or 3-day busulfan in patients allografted for myeloid neoplasms.

Authors:  Ludek Raida; Zuzana Rusinakova; Edgar Faber; Romana Szotkowska; Peter Rohon; Ivana Skoumalova; Martina Divoka; Zuzana Pikalova; Karel Indrak; Katerina Langova
Journal:  Int J Hematol       Date:  2014-10-11       Impact factor: 2.490

6.  Cytogenetic changes associated with myelodysplastic syndrome affecting bone marrow engraftment analysis.

Authors:  Terence Dunn; Richard Allen; Francesca Bates; Carla Kurkjian; Rammurti Kamble; Mohamed Kharfan-Dabaja
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

7.  Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT.

Authors:  Courtney D Fitzhugh; Matthew M Hsieh; Tiffani Taylor; Wynona Coles; Katherine Roskom; Delon Wilson; Elizabeth Wright; Neal Jeffries; Christopher J Gamper; Jonathan Powell; Leo Luznik; John F Tisdale
Journal:  Blood Adv       Date:  2017-04-19

8.  Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.

Authors:  Matthew M Hsieh; Elizabeth M Kang; Courtney D Fitzhugh; M Beth Link; Charles D Bolan; Roger Kurlander; Richard W Childs; Griffin P Rodgers; Jonathan D Powell; John F Tisdale
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

9.  A SNP panel for early detection of artificial chimerism in HSCT patients using TaqMan technology.

Authors:  Tikumphorn Sathirapatya; Wikanda Worrapitirungsi; Poonyapat Sukawutthiya; Kawin Rasmeepaisarn; Kornkiat Vongpaisarnsin
Journal:  Int J Legal Med       Date:  2020-04-05       Impact factor: 2.686

10.  Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

Authors:  Matthew M Hsieh; Courtney D Fitzhugh; R Patrick Weitzel; Mary E Link; Wynona A Coles; Xiongce Zhao; Griffin P Rodgers; Jonathan D Powell; John F Tisdale
Journal:  JAMA       Date:  2014-07-02       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.